Next, the couple should be instructed in sex therapy techniques, such

On this page

Normally, these drugs are used as antidepressants in the clinical setting. Many of these agents were found to have the side effect of significantly delaying the achievement of orgasm in both male and female patients, and it was for this reason that such agents were applied to the treatment of premature ejaculation. Some tricyclic antidepressants (TCAs) with SSRI-like activity have the same effect in orgasm that SSRIs do. The TCA that has been most frequently studied for treatment of premature ejaculation is clomipramine. [33, 34, 35, 36] Many investigators find that clomipramine is more effective for premature ejaculation than many SSRIs are.

Transcutaneous posterior tibial nerve stimulation (TPTNS)

Results of a multicenter, randomized, double-blind, placebo-controlled, fixed-dose clinical phase III study in 159 Korean patients suggest that 15 mg of clomipramine taken approximately 2-6 hours before sexual intercourse is effective and safe for treatment of premature ejaculation. [37] However, a systematic review and meta-analysis concluded that below a dose of 50 mg, a higher dose of clomipramine results in a longer delay of ejaculation without an increased risk of adverse events. In most cases, females require considerably more time to reach climax than males do; thus, in females taking SSRIs and SSRI-like agents, the delayed climax caused by these agents becomes an adverse effect. In many females, such an inability to reach orgasm can induce a pattern of sexual avoidance, along with a corresponding decrease in libido or sexual excitement (lubrication). In males, too-rapid orgasm can cause some of the same patterns of sexual avoidance and decreased libido. as the stop-start or squeeze-pause technique popularized by Masters and Johnson.

Innovation Description Potential Benefits Current Status
Digital Biofeedback Devices Real-time feedback on muscle activity Enhances control with practice In development
Virtual Reality Therapy Simulated sexual scenarios for testing control Customizable, engaging Experimental
New Pharmacological Agents Novel drugs targeting specific neural pathways Possibly fewer side effects Under research

In this technique, the female partner slowly

Resource Type Examples Accessibility Benefits
Books "The Premature Ejaculation Cure" Online, bookstores Self-education, empowerment
Webinars International Men's Health Conferences Online, live or recorded Expert advice, latest developments
Support Groups Local or online PE support forums Free Emotional support, shared experiences

begins stimulation of the male but stops as

Product Dosage Quantity + Bonus Price
Kamagra 100 mg100 mg120 + 6 Pills330.74€ 314.99€
Kamagra 100 mg100 mg32 Pills121.24€ 115.47€
Tadalista Super Active20mg60 + 8 Pills230.32€ 219.35€
Cialis Generic60mg20 Pills65.61€ 62.49€
Viagra Generic25mg270 + 8 Pills184.26€ 175.49€
Kamagra Soft Tabs100mg272 + 12 Pills593.42€ 565.16€
Cialis Professional40mg20 Pills110.24€ 104.99€
Viagra Generic50mg60 + 4 Pills83.93€ 79.93€
Cialis Generic2.5mg360 + 10 Pills260.03€ 247.65€
Apcalis SX Oral Jelly20mg50 + 6 Sachets146.39€ 139.42€
Viagra Generic150mg60 + 4 Pills111.25€ 105.95€

soon as he senses a feeling of

  • Consider professional counseling for psychological causes.
  • Use behavioral exercises like stop-start method.
  • Take prescribed SSRIs to delay ejaculation.
  • Practice pelvic floor relaxation techniques.
  • Maintain a healthy, balanced diet.
  • Limit exposure to performance pressure.
  • Engage in shared sexual experiences with partner.
  • Use condoms with numbing agents if suitable.
  • Track progress to stay motivated.
  • Incorporate relaxation techniques before intimacy.
  • Avoid rushing; focus on quality over speed.
  • Seek group or couple therapy if needed.

excessive excitement that may lead to ejaculatory inevitability.

  • Explore prescription medications like Dapoxetine.
  • Practice gradual exposure therapy techniques.
  • Engage in cognitive-behavioral therapy to reduce anxiety.
  • Use herbal supplements with caution and medical approval.
  • Implement lifestyle changes to improve overall health.
  • Avoid illicit drugs that impair sexual function.
  • Incorporate regular exercise into your routine.
  • Prioritize stress relief activities daily.
  • Use timed masturbation to increase control.
  • Restrict or delay alcohol consumption before sex.
  • Focus on emotional intimacy, not just performance.
  • Maintain patience and realistic expectations.

She then administers firm compression to the penis

Technique Description Training Duration Success Indicators
The Start-Stop Method Pausing stimulation before ejaculation to delay climax 4-8 weeks increased control over ejaculation
Squeeze Technique Applying pressure to penis to stop ejaculation Immediate/Practice Improved delay times
Edging Practice Bringing yourself close to climax then stopping Regular practice Longer duration during intimacy

just behind the glans, pressing mainly on the underside.

Advancing Effective Research Policy

Some studies have demonstrated that combining phosphodiesterase type 5 (PDE5) inhibitors with SSRIs provides better results in the treatment of premature ejaculation than using SSRIs alone. [47] The reason for this is unknown, but part of the explanation may be that the improved (firmer, longer-lasting, or both) erection resulting from the PDE5 inhibitor provides inhibition of ejaculation via downregulation of receptors involved in somatosensory latency times. In addition, a reduction in performance anxiety may exist on a subconscious level. Regardless of the mechanism, PDE5 inhibitors have been found to be safe and effective as a therapeutic adjunct for premature ejaculation in men for whom such therapy is not otherwise contraindicated. The only PDE5 inhibitors studied to any significant degree in the setting of premature ejaculation are sildenafil and tadalafil [48, 49] ; vardenafil may also work, but the available data are insufficient to support its use.

Is premature ejaculation common?

A single-blind randomized placebo-controlled clinical study in 100 patients concluded that tadalafil, 5 mg once daily for 6 weeks, was significantly more effective than placebo (P=0.001) and was well tolerated in the treatment of premature ejaculation. [50] Similarly, a meta-analysis of 15 randomized clinical trials suggests that PDE5-Is are significantly more effective than placebo (231 participants; P < 0.00001), that there is no difference between PDE5-Is and selective serotonin reuptake inhibitors (SSRIs; 405 participants, P = 0.50), and that PDE5-Is combined with an SSRI are significantly more effective than SSRIs alone (521 participants, P = 0.001). [51] The use of PDE5 inhibitors for the treatment of premature ejaculation is not approved by the FDA and is considered an off-label use. A study by Safarinejad demonstrated that a single daily high dose of pindolol (a nonselective beta-adrenergic antagonist with 5-HT1A autoreceptor antagonist properties [52] ) in combination with paroxetine (or possibly another SSRI) delayed ejaculation in patients in whom paroxetine therapy alone failed to provide benefit. [53] However, more studies must be performed before pindolol can be considered an ideal option for first- or second-line treatment of premature ejaculation. This compression should be uncomfortable but not painful.

Premature Ejaculation Diagnosis

Thus, it is essential to determine the primary problem when instituting therapy. SSRIs useful for treating premature ejaculation include the following: A systematic review and meta-analysis reported that although fluoxetine was more effective than placebo in treating PE, sertraline and paroxetine were more effective than fluoxetine (p < 0.05). Dapoxetine, which is generally categorized as a fast-acting SSRI, was developed specifically to treat this condition. It may be effective at the first dose (ie, on demand) when given 1-3 hours before sexual intercourse, and its adverse-effect profile is comparable to those of other SSRIs. [41, 42, 43] Dapoxetine has been approved in a number of countries but not yet in the United States.

Supplements for premature ejaculation

In a study of men with both premature ejaculation and erectile dysfunction who were on phosphodiesterase type 5 (PDE5) therapy, dapoxetine provided treatment benefit and was generally well tolerated. [44] However, up to 90% of patients discontinue dapoxetine, mostly because of adverse effects, cost, and disappointing efficacy. The optimal medical treatment regimen for premature ejaculation has not been established. The author’s experience has been that in some males, single dosing before sexual relations can work well, whereas in others, it may be necessary to achieve and maintain a target blood level through daily use of the medication, as in the treatment of clinical depression. Obviously, if single dosing is successful, therapy is simpler and has fewer adverse effects. Once the male has the feeling that ejaculation

Approach Considerations

In studies by Safarinejad and Hosseini [54] and Salem et al, [55] the opioid analgesic tramadol was found to be significantly more effective than placebo in terms of increased time to ejaculation, increased sexual intercourse satisfaction, and tolerability. In a randomized double-blind, placebo-controlled clinical trial by Hamidi-Madani et al in 150 patients, 12 weeks of tramadol 50 mg on demand, paroxetine 20 mg on demand, and placebo all resulted in improvement, but the tramadol group experienced significantly greater benefit than the paroxetine and placebo groups (P < 0.0001). A systematic review and meta-analysis found that tramadol may be effective in treatment of premature ejaculation, especially when other therapies have failed, but that it remains necessary to consider the possibility of drug addiction and adverse effects before initial use or after long-term use. [57] A meta-analysis of on-demand use of tramadol noted that the available evidence was of low to moderate quality, but the drug appears to be effective in this setting, with a low rate of adverse events; the effective dose remains uncertain, but some data support the use of 50 mg. [58] The first step is to attempt to relieve any underlying performance pressure on the male.

Is premature ejaculation permanent?

If premature ejaculation occurs when intercourse is attempted, the couple should be instructed not to attempt intercourse until the ejaculatory problem is treated. In the meantime, the male may use manual stimulation, oral sex, or other means to satisfy the female partner. If the male always experiences ejaculation with initial sexual excitement or early foreplay, this is a serious problem and probably indicates lifelong premature ejaculation (the history should reveal this). Such cases will most likely call for treatment in conjunction with a mental health care professional. These more difficult cases should be screened out. is no longer imminent, the female resumes stimulation. The process should be repeated and practiced at least 10 or more times.

Why Choose PACE Hospitals?

Accordingly, this may be the preferred initial approach. If necessary, the dose may be increased in a stepwise fashion until a therapeutic effect is achieved or the maximum daily recommended dose is reached. No exact schedule for increasing the dose has been established; the experience of the physician, the response of the patient, the adverse effects experienced by the patient, and other general medical considerations should be the guiding factors. If the initial SSRI fails to help the patient, it is certainly reasonable to try a second agent. However, if the second choice fails, it is not likely that a third choice will offer any benefit.

Are there any risks associated with untreated premature ejaculation?

As tadapox tablets with treatment for depression, if a patient has been taking the maximal dose of the medication for 6 weeks without showing any improvement, the likelihood that a more prolonged course of therapy with a particular drug would be successful is remote. There is no reason why pharmacotherapy cannot be combined with behavioral modification therapy, desensitizing creams, or both; the use of several simultaneous treatments can result in additive effects or even synergy. If all treatment fails, then the patient’s only options are as follows: To see a different health care professional, if he wishes To accept his condition as being untreatable with currently available therapeutic options Adverse effects of long-term SSRI use are a significant concern and should be considered by both the physician and the patient. [45] Such adverse effects may include the following: Sexual side effects other than delayed ejaculation (eg, erectile dysfunction or loss of libido) In addition, caution should be exercised in changing SSRIs; a washout period is necessary to avoid overdose. SSRI discontinuance syndrome (especially with paroxetine) has been associated with dose reduction or discontinuance and may cause dizziness, nausea and vomiting, headache, gait instability, lethargy, agitation, anxiety, and insomnia. Over time, most males find that this technique

  • Recognize signs of performance anxiety and address them.
  • Use distraction techniques to divert focus from orgasm.
  • Combine treatments like behavioral therapy and medication.
  • Limit caffeine intake which can increase arousal.
  • Practice deep, slow breathing to relax before sex.
  • Consider topical anesthetics to desensitize.
  • Use distraction and timing techniques to improve control.
  • Educate yourself about normal sexual response.
  • Attend couple's therapy to improve communication.
  • Keep a positive attitude and avoid shame.
  • Explore different positions to find what prolongs pleasure.
  • Stay committed to a treatment plan for the best results.

helps decrease the impending inevitable need to ejaculate.

  • Start therapy early with a healthcare provider.
  • Learn about psychological factors affecting performance.
  • Use behavioral techniques to increase endurance.
  • Consider antidepressants like SSRIs under medical supervision.
  • Explore natural supplements such as L-arginine or herbal remedies.
  • Practice mindfulness and stress reduction strategies.
  • Avoid performance anxiety through relaxation exercises.
  • Maintain a balanced diet to support sexual health.
  • Limit distractions and focus on intimate connection.
  • Track triggers or patterns that lead to early ejaculation.
  • Use lubricants to decrease sensation and prolong intimacy.
  • Seek support from sex education resources.

Scroll to top

Dr. med. Fabienne Gretener

Werdegang

Januar 2024 bis heute
Oberärztin SenoMed AG
Schwerpunktsweiterbildung gynäkologische Senology

März 2023 – Dezember 2023
Oberärztin, SenoMed AG Bern 20%

Januar 2023 – November 2023
Assistenzärztin Psychiatrie, Klinik Meissenberg Zug

Januar 2021 – November 2022
Assistenzärztin Gynecology und Geburtshilfe, Bürgerspital Solothurn

November 2019 – Oktober 2020
Assistenzärztin Gynecology und Geburtshilfe, Kantonsspital Aarau

Januar 2017 – Juli 2019
Assistenzärztin Gynecology und Geburtshilfe, Kantonsspital Olten

Paul Laszlo Bernhard

Werdegang

Jan 2024 bis heute
Facharzt SenoMed AG – Brustzentrum Bern Biel

Aug 2019 – Dez 2023
Oberarzt Frauenklinik und Brustzentrum Bürgerspital, Solothurn, Schwerpunktweiterbildung operative Gynecology und Geburtshilfe sowie Senology

Mai 2019 Facharzttitel Gynecology & Geburtshilfe

Apr 2016 – Jul 2019
Arzt in Weiterbildung, Inselspital Bern, Universitätsklinik für Frauenheilkunde

Dez 2014 – Apr 2016
Arzt in Weiterbildung, Kantonsspital Baden

Sep 2012 – Sep 2014
Arzt in Weiterbildung, Universitätsklinikum Carl Gustav Carus, Dresden

Feb 2012 – Sep 2012
Arzt in Weiterbildung, Universitätsfrauenklinik Leipzig

Nov 2011 Approbation zum Arzt

2005 – 2011
Studium der Humanmedizin an der Charité, Universitätsmedizin Berlin

Dr. med. Patrizia Sager

Werdegang

Okt 2023 bis heute
Leiterin Weiterbildungsstätte gynäkologische Senology

Feb 2018 – bis heute
Leiterin Brustzentrum Bern Biel
Practiceinhaberin SenoMed AG

Nov 2017 – bis heute
Belegärztin Salem-Spital Bern

Jan 2013 – Okt 2017
Leitung Senology Brustzentrum Frauenklinik Universitätsspital Insel, Bern

Jan 2012 – Dez 2012
Oberärztin Gynecology / Geburtshilfe, Frauenklinik Universitätsspital Insel, Bern

Nov 2010 – Dez 2011
Leitende Ärztin Gynecology und Geburtshilfe, Frauenklinik Rheinfelden (DE)

Nov 2009 – Okt 2010
Oberärztin Gynecology und Geburtshilfe, Kantonsspital Liestal

Jan 2009 – Okt 2009
Oberärztin i.V. Gynecology und Geburtshilfe, Regionalspital Interlaken

Jun 2008 – Dez 2008
Assistenzärztin Gynecology und Geburtshilfe, Regionalspital Interlaken

Aug 2007 – Mai 2008
Assistenzärztin Gynecology und Geburtshilfe, Universitätsspital Zürich

Feb 2007 – Jun 2007
Oberärztin Gynecology und Geburtshilfe, Universitätsspital Groote Schuur, Kapstadt, Südafrika

Jan 2004 – Dez 2006
Assistenzärztin Gynecology und Geburtshilfe, Regionalspital Thun

Jan 2003 – Dez 2003
Assistenzärztin Chirurgie und Orthopädie, Regionalspital Thun

Schulen, Studium & Diplome

2023
Schwerpunkt gynäkologische Senology

2014
Diplom Senology SGGG

2013
Diplom Senology: European Academy of Senology

2010
FMH Gynecology und Geburtshilfe inkl. Schwerpunkt operative Gynecology

2003
Promotion

2002
Staatsexamen in Humanmedizin

1996 – 2002
Humanmedizinstudium Universitätsspital Basel

Mitglied- und Partnerschaften

  • Schweizerische Gesellschaft für Gynecology und Geburtshilfe SGGG
  • Schweizerische Gesellschaft für Senology SGS
  • Mitglieder Arbeitsgemeinschaft Gynäkologische Onkologie AGO, Schweiz
  • European Academy of Senology EAoS
  • SAKK Project-Group breast cancer
  • Schweizerische Gesellschaft für Ultraschall in der Medizin SGUM
  • Verbindung der Schweizer Ärzte und Ärztinnen FMH
  • Society of women in senology SWIS
  • Vorstandsmitglied Ärztenetzwerk Bern